BioMark Diagnostics Inc.
BUX
Rankning i aktier
#26628
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Aktiekurs
$0.33433516
Senast synkroniserad: 2026-10-20
Marknadsvärde
$35.60M
Förändring (1 dag)
-3.08%
Förändring (1 år)
39.31%
Land
CA
Handel BioMark Diagnostics Inc. (BUX)
Kategori
Healthcare
Aktiekurshistorik för BioMark Diagnostics Inc. (BUX)
Högsta slutkurs: $0.38 den 2026-10-01
Lägsta slutkurs: $0.35 den 2015-03-01
Lägsta slutkurs: $0.35 den 2015-03-01
Aktiekurshistorik för BioMark Diagnostics Inc. från 2015 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 6.88% |
| 2025 | 136.71% |
| 2024 | -19.87% |
| 2023 | 29.58% |
| 2022 | -34.72% |
| 2021 | 122.09% |
| 2020 | -51.07% |
| 2019 | 376.19% |
| 2018 | -44.93% |
| 2017 | -9.77% |
| 2016 | -22.98% |
| 2015 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
